- Home
- AMBC vs LXRX Comparison
AMBC vs LXRX Comparison
Compare AMBC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- LXRX
- Stock Information
- Founded
- AMBC 1971
- LXRX 1995
- Country
- AMBC United States
- LXRX United States
- Employees
- AMBC N/A
- LXRX N/A
- Industry
- AMBC Property-Casualty Insurers
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- LXRX Health Care
- Exchange
- AMBC Nasdaq
- LXRX Nasdaq
- Market Cap
- AMBC 411.3M
- LXRX 428.8M
- IPO Year
- AMBC 1991
- LXRX 2000
- Fundamental
- Price
- AMBC $8.69
- LXRX $1.19
- Analyst Decision
- AMBC Strong Buy
- LXRX Buy
- Analyst Count
- AMBC 2
- LXRX 5
- Target Price
- AMBC $12.50
- LXRX $3.23
- AVG Volume (30 Days)
- AMBC 780.4K
- LXRX 2.4M
- Earning Date
- AMBC 08-07-2025
- LXRX 08-06-2025
- Dividend Yield
- AMBC N/A
- LXRX N/A
- EPS Growth
- AMBC N/A
- LXRX N/A
- EPS
- AMBC N/A
- LXRX N/A
- Revenue
- AMBC $257,879,000.00
- LXRX $58,432,000.00
- Revenue This Year
- AMBC N/A
- LXRX N/A
- Revenue Next Year
- AMBC $18.20
- LXRX N/A
- P/E Ratio
- AMBC N/A
- LXRX N/A
- Revenue Growth
- AMBC 148.44
- LXRX 1504.83
- 52 Week Low
- AMBC $5.99
- LXRX $0.28
- 52 Week High
- AMBC $13.64
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- AMBC 59.25
- LXRX 56.85
- Support Level
- AMBC $7.85
- LXRX $1.12
- Resistance Level
- AMBC $8.64
- LXRX $1.27
- Average True Range (ATR)
- AMBC 0.43
- LXRX 0.09
- MACD
- AMBC 0.03
- LXRX -0.00
- Stochastic Oscillator
- AMBC 95.81
- LXRX 68.00
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.